Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding Gefitinib to combination chemotherapy and radiation therapy improves outcomes for unresectable stage III non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Stage Iiia Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 3 | Status: COMPLETED